Shopping Cart
- Remove All
- Your shopping cart is currently empty
SCD1 inhibitor-3 (ML-270) is a highly effective and orally available compound that inhibits SCD1 with remarkable safety. SCD1 inhibitor-3 demonstrates strong potential for research in metabolic diseases, including obesity, type II diabetes, and dyslipidemia, as well as various skin conditions like acne and cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $84 | In Stock | |
5 mg | $197 | In Stock | |
10 mg | $313 | In Stock | |
25 mg | $533 | In Stock | |
50 mg | $768 | In Stock | |
100 mg | $1,080 | In Stock | |
1 mL x 10 mM (in DMSO) | $216 | In Stock |
Description | SCD1 inhibitor-3 (ML-270) is a highly effective and orally available compound that inhibits SCD1 with remarkable safety. SCD1 inhibitor-3 demonstrates strong potential for research in metabolic diseases, including obesity, type II diabetes, and dyslipidemia, as well as various skin conditions like acne and cancer. |
In vivo | SCD1 inhibitor-3 (compound 17a), administered orally at a dosage of 5 mg/kg for 4 hours, effectively decreases the plasma C16:1/C16:0 triglycerides desaturation index by 54% in Lewis rats [1]. Furthermore, a dose-responsive reduction in the plasma triglycerides desaturation index is observed when the dosage ranges from 2 to 10 mg/kg, under the same conditions, indicating a dose-dependent efficacy [1]. |
Alias | SCD1-IN-3, SCD1 inhibitor-3, SCD1 inhibitor 17a |
Molecular Weight | 393.37 |
Formula | C19H16FN7O2 |
Cas No. | 1282606-48-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 35 mg/mL (89 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.